Climb Biotherapeutics, Inc. Intrinsic Value
CLYM
Climb Biotherapeutics fair value
None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Climb Biotherapeutics today, so there is nothing to project yet.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CLYM
Held by ETFs
CLYM is in 15 US ETFs. The largest of them, with CLYM's weight in each:
iShares Russell 2000 Growth ETFIWO0.01%of the fund
State Street SPDR S&P Biotech ETFXBI0.11%of the fund
Vanguard U.S. Momentum Factor ETFVFMO0.12%of the fund
Vanguard Russell 2000 Growth ETFVTWG0.01%of the fund
iShares Micro-Cap ETFIWC0.09%of the fund
Fidelity Fundamental Small-Mid Cap ETFFFSM0.11%of the fund
Spot a number that looks wrong? Check it in CLYM's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CLYM
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.